MAPT and Alzheimer disease: Given that APP-models were able to generate hyperphosphorylated tau (ptau), but not intraneuronal neurofibrillary tangles (NFTs), the incorporation of mutated MAPT gene allowed for investigating the tauopathy component of AD [7].